Home » High-Quality Health Information » Health Topics » Ewing's Sarcoma » Study: NCT00295919

| Print this page

• Home
• High-Quality
  Health Information
  • Health Topics
  • Health Resources
• Understanding Health Research
  • What is health research?
  • Is health research safe?
  • Is health research
    right for me?
• Health Research in Massachusetts
  • Search Ongoing Studies
  • Community-Engaged Research Projects
  • Community Health Centers

Title:	Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
Status:	Recruiting participants
Conditions:	Neuroblastoma
Interventions:	Drug: fenretinide lipid matrix; Drug: ketoconazole; Other: laboratory biomarker analysis; Other: pharmacological study
Institutions:	Children's Hospital Boston
Health Topics:	Ewing's Sarcoma, Neuroblastoma
View this study on ClinicalTrials.gov

Contact Information

---

© Community Connect to Research, 2012